The viral oncoprotein E1A blocks transforming growth factor β-mediated induction of p21/WAF1/Cip1 and p15/INK4B

Molecular and Cellular Biology

Volumn 17, Issue 4, 1997, Pages 2030-2037

  Datto, Michael B ^a   Hu, Patrick Pei Chih ^a   Kowalik, Timothy F ^a,b   Yingling, Jonathan ^a   Wang, Xiao Fan ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; GENE PRODUCT; ONCOPROTEIN; PROTEIN P21; TRANSFORMING GROWTH FACTOR BETA; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE;

EID: 0030938916     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.17.4.2030     Document Type: Article

References (58)

1. Abraham, S. E., M. C. Carter, and E. Moran. 1992. Transforming growth factor β1 (TGFβ1) reduces cellular levels of p34cdc2 and this effect is abrogated by adenovirus independently of the E1A-associated pRB binding activity. Mol. Biol. Cell 3:655-665.
2. Arany, Z., W. R. Sellers, D. M. Livingston, and R. Eckner. 1994. E1A associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77:799-800.
3. Bandara, L. R., and N. B. LaThangue. 1991. Adenovirus E1A prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature 351:494-497.
4. Bremner, R., B. L. Cohen, M. Sopta, P. A. Hamel, C. J. Ingles, B. L. Gallie, and R. A. Phillips. 1995. Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol. Cell. Biol. 15:3256-3265.
5. Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097-1105.
6. Chellappan, S. P., S. Hiebert, M. Mudryj, M. Horowitz, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053-1061.
7. Chen, P.-L., P. Scully, J.-Y. Shew, J. Y. J. Wang, and W.-H. Lee. 1989. Phosphotylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193-1198.
8. Datto, M. B., Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, and X.-F. Wang. 1995. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92:5545-5549.
9. 8a. Datto, M. B., and X.-F. Wang. Unpublished data.
10. Datto, M. B., Y. Yu, and X.-F. Wang. 1995. Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270:28623-28628.
11. DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, H. Piwnica-Worms, C. M. Huang, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085-1095.
12. 1/S-regulatory genes. Mol. Cell. Biol. 15:4215-4224.
13. Eckner, R., M. E. Ewen, D. Newsom, M. Gerdes, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:869-884.
14. Elbendary, A., A. Berchuck, P. Davis, L. Havrilesky, R. C. Bast, J. D. Iglehart, and J. R. Marks. 1994. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ. 5:1301-1307.
15. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
16. Ewen, M. E., H. K. Slus, C. J. Sherr, H. Matsushime, J.-Y. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:293-302.
17. Ewen, M. E., Y. G. Wing, J. B. Lawrence, and D. M. Livingston. 1991. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66:1155-1164.
18. Hannon, G. J., D. Demetrick, and D. Beach. 1993. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev. 7:2378-2391.
19. Hannon, G. J., and D. Beach. 1994. P15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257-260.
20. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
21. Hu, Q., C. Bautista, G. M. Edwards, D. Defeo-Jones, R. E. Jones, and E. Harlow. 1991. Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides. Mol. Cell. Biol. 11:5792-5799.
22. Hunter, T., and J. Pines. 1994. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573-582.
23. Ikeda, M.-A., and J. R. Nevins. 1993. Identification of distinct roles for separate E1A domains in disruption of E2F complexes. Mol. Cell. Biol. 13:7029-7035.
24. Koff, A., M. Ohtsuki, K. Polyak, J. M. Roberts, and J. Massague. 1993. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-β. Science 260:536-539.
25. 12S product involves separate E1A domains. Mol. Cell. Biol. 12:4391-4399.
26. Laiho, M., J. A. DeCaprio, J. W. Ludlow, D. M. Livingston, and J. Massague. 1990. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175-185.
27. Lee, J.-S., R. H. See, T. Deng, and Y. Shi. 1996. Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300. Mol. Cell. Biol. 16:4312-4326.
28. Lee, J.-S., S. Zhang, and Y. Shi. 1996. Differential interactions of the CREB/ ATF family of transcription factors with p300 and adenovirus E1A. J. Biol. Chem. 271:17666-17674.
29. Li, C.-Y., L. Suardet, and J. B. Little. 1995. Potential role of WAF1/Cip1/p21 as a mediator of TGF-β cytoinhibitory effect. J. Biol. Chem. 270:4971-4974.
30. Li, J.-M., M. A. Nichols, S. Chandrasekharan, Y. Xiong, and X.-F. Wang. 1995. Transforming growth factor β activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J. Biol. Chem. 270:26750-26753.
31. Li, Y., C. Graham, S. Lacy, A. M. Duncan, and P. Whyte. 1993. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev. 7:2366-2377.
32. Mal, A., R. Y. C. Poon, P. H. Howe, H. Toyoshima, T. Hunter, and M. L. Harter. 1996. Inactivation of p27Kip1 by the viral E1A oncoprotein in TGF-β treated cells. Nature 380:262-265.
33. Mihara, K., X.-R. Cau, A. Yen, S. Chandler, B. Driscoll, A. L. Murphee, A. T'Ang, and Y.-K. T. Fung. 1989. Cell cycle dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246:1300-1303.
34. Missero, C., E. Filvaroff, and G. P. Dotto. 1991. Induction of transforming growth factor β1 resistance by the E1A oncogene requires binding to a specific set of cellular proteins: Proc. Natl. Acad. Sci. USA 88:3489-3493.
35. Moran, E., and M. B. Mathews. 1987. Multiple functional domains in the adenovirus E1A gene. Cell 48:177-178.
36. Moran, E., and B. Zerler. 1988. Interactions between cell growth regulating domains in the products of the adenovirus E1A oncogene. Mol. Cell. Biol. 8:1756-1764.
37. Moran, E., B. Zerler, T. M. Harrison, and M. B. Mathews. 1986. Identification of separate domains in the adenovirus E1A gene for immortalization activity and the activation of virus early genes. Mol. Cell. Biol. 6:3470-3480.
38. Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-428.
39. Nevins, J. R. 1995. Adenovirus E1A: transcription regulation and alteration of cell growth control. Curr. Top. Microbiol. Immunol. 199:25-32.
40. Ohtsubo, M., and J. M. Roberts. 1993. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259:1908-1912.
41. 1-to-S phase transition. Mol. Cell. Biol. 15:2612-2624.
42. Peter, M., and I. Herskowitz. 1994. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79:181-184.
43. Pietenpol, J. A., R. W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R. M. Lyons, M. R. Pittelkow, K. Munger, P. M. Howley, and H. L. Moses. 1990. TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777-783.
44. Polyak, K., J.-Y. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A. Koff. 1994. p27Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9-12.
45. Polyak, K., M.-H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
46. Ravchaudhuri, P., S. Bagchi, S. H. Devoto, V. B. Kraus, E. Moran, and J. K. Nevins. 1991. Domains of the adenovirus E1A protein that are required for oncogenic activity are required for dissociation of cellular transcription factor complexes. Genes Dev. 5:1200-1211.
47. 1-to-S transition. Mol. Cell. Biol. 15:3463-3469.
48. Reynisdottir, I., K. Polyak, A. Iavarone, and J. Massague. 1995. Kip/Cip and Ink4 inhibitors cooperate to induce cell cycle arrest in response to TGr-β. Genes Devel. 9:1831-1845.
49. Sherr, C. J. 1993. Mammalian G1 cyclins. Cell 73:1059-1065.
50. Waga, S., G. Hannon, D. Beach, and B. Stillman. 1994. The p21 inhibitor of cyclin dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578.
51. Wang, H.-G. H., G. Draetta, and E. Moran. 1991. E1A induces phosphorylation of the retinoblastoma protein independently of direct physical association between the E1A and retinoblastoma products. Mol. Cell. Biol. 11:4253-4265.
52. Weinberg, R. A. 1996. E2F and cell proliferation: a world turned upside down. Cell 85:457-459.
53. Weintraub, S. J., K. N. B. Chow, R. X. Luo, S. H. Zhang, S. He, and D. C. Dean. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375:812-815.
54. Whyte, P. K. 1995. The retinoblastoma protein and its relatives. Semin. Cancer Biol. 6:83-90.
55. Whyte, P. K., K. J. Buchkovich, J. M. Horowitz, S. H. Friend, M. Raybuck, R. A. Weinberg and E. Harlow. 1988. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334:124-129.
56. Whyte, P. K., N. M. Williamson, and E. Harlow. 1989. Cellular targets for transformation by adenovirus E1A proteins. Cell 56:67-75.
57. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. P21 is a universal inhibitor of cyclin kinases. Nature 366:701-704.
58. Yingling, J. M., X.-F. Wang, and C. H. Bassing. 1995. Signaling by the transforming growth factor-β receptors. Biochim. Biophys. Acta 1242:115-136.